The aim of the present work was to perform subacute toxicity study of lacidipine nanoformulation in Wistar rats. Solid lipid nanoparticles (SLNs) of lacidipine was formulated using ultrasound dispersion technique. Subacute toxicity study was carried out by administrating orally SLNs containing 0.140, 0.350, and 0.875 mg of lacidipine as low, medium and high dose per kg body weight, respectively, along with blank formulation and standard drug (lacidipine). Control group rats received Milli Q water. Doses were administered once daily over a period of 28 days. Animals were observed for morphological parameters of toxicity during study period and their body weight were recorded once weekly. Overnight fasted rats were sacrificed on 29th day and assessment of haematological, biochemical parameters and histopathological analysis of brain, heart, kidney and liver were carried out. The results suggest SLNs formulation of lacidipine do not cause toxicity or adverse effect in rats.
|Number of pages||8|
|Journal||Latin American Journal of Pharmacy|
|Publication status||Published - 26-09-2015|
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
- Drug Discovery